Prognostic value of epicardial adipose tissue in heart failure: a systematic review and meta-analysis
Frontiers in Cardiovascular Medicine · 26.06.2025 · 12
DOI: 10.3389/fcvm.2025.1618614 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 26.06.2025. Verfasst von Qingqun Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Epicardial adipose tissue (EAT) essentially affects the pathophysiologic development of heart failure (HF), while existing research has not well elucidated its prognostic value for outcome. The present study aims at including relevant studies for systematically assessing its prognostic value in HF patients.
Methods
The studies assessing the way EAT was employed to predict adverse HF outcomes were included from PubMed, Web of Science, Embase, and the Cochrane Library databases, and relevant data were accurately extracted. The primary outcome included the composite outcome of HF hospitalization and all-cause mortality (ACM). Secondary outcomes were the composite outcome of cardiovascular death and HF hospitalization and HF rehospitalization. We combined the standard mean difference (SMD) of EAT in HF patients with and without adverse events (AEs) and the EAT to adverse outcome hazard ratio (HR).
Results
The nine included studies involved 1,939 HF patients and 329 control populations. HF patients with AEs presented a higher EAT vs. those without (SMD: 3.33, CI: 0.96–5.69, p = 0.006, I 2 = 98%). Increased EAT per unit indicated a higher risk of the composite outcome of HF hospitalization and all-cause mortality (HR: 1.28, CI: 1.42–1.85, p = 0.0002, I 2 = 93%) and HF readmission (HR: 1.05, CI: 1.03–1.07, p < 0.001, I 2 = 10%), but did not relate to that of cardiovascular death and HF hospitalization (HR: 1.17, CI: 0.99–1.39, p = 0.06, I 2 = 76%). The pooled AUC value for EAT to predict the primary outcome was 0.74 (CI: 0.66–0.82, p = 0.018, I 2 = 70.1%) in HF patients with EF >40%.
Conclusion
EAT is considered a clinical predictor of the composite outcome of HF hospitalization and ACM and may contribute to the prediction of poor prognosis in HF patients. Systematic Review Registration https://www.crd.york.ac.uk/ , identifier [CRD420250653252].
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Zitieren
APA
Wu, Q., Guo, J., Liu, F., Dong, C., Wang, Y., Liu, L., & Zhang, S. (2025). Prognostic value of epicardial adipose tissue in heart failure: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1618614
Vancouver
Wu Q, Guo J, Liu F, Dong C, Wang Y, Liu L, et al. Prognostic value of epicardial adipose tissue in heart failure: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1618614
BibTeX
@article{Wu2025,
author = {Wu, Qingqun and Guo, Junhan and Liu, Fengru and Dong, Chenchen and Wang, Yu and Liu, Lu and Zhang, Shulong},
title = {Prognostic value of epicardial adipose tissue in heart failure: a systematic review and meta-analysis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1618614}
}
EUVIMED